Remote Smoking Cessation in Hospitalized Cardiac Patients
ConditionSmoking Cessation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Vermont Medical Center
About this trial
The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects. The proposed trial can provide significant knowledge for promoting adherence to smoking cessation guidelines in patients with cardiac disease
Eligibility criteria
Qualifiers
Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)
live within 30 miles of UVMMC and are >18 years of age
Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and >5 cigarette/day on average over the past 3 months)
Disqualifiers
severe dementia/Alzheimer's disease
an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance
exercise limiting vascular or neuromuscular disease
Non-English Speaking
Trial design
Treatments tested in this trial
- Financial Incentives (FI) and Nicotine Replacement Therapy (NRT)
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov